Advertisement
U.S. Markets closed
S&P Futures
5,888.00 -4.50 (-0.08%) Dow Futures
43,047.00 -122.00 (-0.28%) Nasdaq Futures
20,518.00 -24.00 (-0.12%) Russell 2000 Futures
2,244.60 -1.60 (-0.07%) Crude Oil
72.24 +0.15 (+0.21%) Gold
2,752.70 -7.10 (-0.26%)
Simcere Pharmaceutical Group Limited (2096.HK)
HKSE - HKSE Delayed Price. Currency in HKD
Follow
As of 10:08AM HKT. Market open.
Currency in HKD
Valuation Measures4
| Market Cap (intraday) | 16.31B |
| Enterprise Value | 14.26B |
| Trailing P/E | 19.67 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.42 |
| Price/Book (mrq) | 2.16 |
| Enterprise Value/Revenue | 2.06 |
| Enterprise Value/EBITDA | 11.84 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.47 |
| 52-Week Change 3 | N/A |
| S&P500 52-Week Change 3 | N/A |
| 52 Week High 3 | 7.870 |
| 52 Week Low 3 | 4.940 |
| 50-Day Moving Average 3 | 6.076 |
| 200-Day Moving Average 3 | 5.724 |
Share Statistics
| Avg Vol (3 month) 3 | 4.35M |
| Avg Vol (10 day) 3 | 9.33M |
| Shares Outstanding 5 | 2.5B |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 705.38M |
| % Held by Insiders 1 | 71.43% |
| % Held by Institutions 1 | 6.88% |
| Shares Short 4 | N/A |
| Short Ratio 4 | N/A |
| Short % of Float 4 | N/A |
| Short % of Shares Outstanding 4 | N/A |
| Shares Short (prior month ) 4 | N/A |
Dividends & Splits
| Forward Annual Dividend Rate 4 | 0.18 |
| Forward Annual Dividend Yield 4 | 2.69% |
| Trailing Annual Dividend Rate 3 | 0.16 |
| Trailing Annual Dividend Yield 3 | 2.35% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 60.24% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | Jun 18, 2024 |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Currency in CNY.Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Jun 30, 2024 |
Profitability
| Profit Margin | -17.39% |
| Operating Margin (ttm) | 18.71% |
Management Effectiveness
| Return on Assets (ttm) | 4.79% |
| Return on Equity (ttm) | -13.81% |
Income Statement
| Revenue (ttm) | 6.34B |
| Revenue Per Share (ttm) | 2.46 |
| Quarterly Revenue Growth (yoy) | -7.90% |
| Gross Profit (ttm) | N/A |
| EBITDA | 1.15B |
| Net Income Avi to Common (ttm) | -1.1B |
| Diluted EPS (ttm) | -0.460 |
| Quarterly Earnings Growth (yoy) | -79.90% |
Balance Sheet
| Total Cash (mrq) | 3.06B |
| Total Cash Per Share (mrq) | 1.21 |
| Total Debt (mrq) | 1.18B |
| Total Debt/Equity (mrq) | 17.11 |
| Current Ratio (mrq) | 2.10 |
| Book Value Per Share (mrq) | 2.72 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.1B |
| Levered Free Cash Flow (ttm) | 74.62M |
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.